OXLC vs. PASG

Last updated Jun 13, 2026

OXLC (Oxford Lane Capital Corp.) and PASG (Passage Bio, Inc.) are both stocks. OXLC operates in Asset Management (Financial Services), while PASG operates in Biotechnology (Healthcare). Over the past 5 years, OXLC returned -7.86%/yr vs -54.00%/yr for PASG. At a 0.12 correlation, their price movements are largely independent.

Performance

OXLC vs. PASG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oxford Lane Capital Corp. (OXLC) and Passage Bio, Inc. (PASG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, OXLC achieves a -27.84% return, which is significantly higher than PASG's -50.76% return.

OXLC

• 1D: -1.41%
• 1M: -8.51%
• YTD: -27.84%
• 6M: -21.18%
• 1Y: -42.28%
• 3Y*: -9.70%
• 5Y*: -7.86%
• 10Y*: 3.38%

PASG

• 1D: 3.75%
• 1M: 5.25%
• YTD: -50.76%
• 6M: -40.68%
• 1Y: -32.71%
• 3Y*: -32.32%
• 5Y*: -54.00%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

OXLC vs. PASG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
OXLC Oxford Lane Capital Corp.	-27.84%	-24.38%	24.58%	16.52%	-24.15%	59.91%	-19.40%
PASG Passage Bio, Inc.	-50.76%	4.04%	-43.85%	-26.81%	-78.27%	-75.17%	14.82%

Correlation

The correlation between OXLC and PASG is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.12
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020	0.12

Fundamentals

Market Cap OXLC : $881.97M PASG : $18.63M
EPS OXLC : -$5.82 PASG : -$11.85
PB Ratio OXLC : 0.86 PASG : 1.58
Total Revenue (TTM) OXLC : $849.13M PASG : $0.00
Gross Profit (TTM) OXLC : $793.40M PASG : -$377.00K
EBITDA (TTM) OXLC : -$578.64M PASG : -$35.03M

Return for Risk

OXLC vs. PASG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OXLC

OXLC Risk / Return Rank: 6
OXLC Sharpe Ratio Rank: 2
OXLC Sortino Ratio Rank: 4
OXLC Omega Ratio Rank: 4
OXLC Calmar Ratio Rank: 11
OXLC Martin Ratio Rank: 7

PASG

PASG Risk / Return Rank: 35
PASG Sharpe Ratio Rank: 32
PASG Sortino Ratio Rank: 43
PASG Omega Ratio Rank: 42
PASG Calmar Ratio Rank: 29
PASG Martin Ratio Rank: 28

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OXLC vs. PASG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oxford Lane Capital Corp. (OXLC) and Passage Bio, Inc. (PASG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	OXLC	PASG	Difference
Sharpe ratio: Return per unit of total volatility	-1.23	-0.27	-0.97
Sortino ratio: Return per unit of downside risk	-1.73	0.46	-2.19
Omega ratio: Gain probability vs. loss probability	0.77	1.06	-0.29
Calmar ratio: Return relative to maximum drawdown	-0.81	-0.41	-0.40
Martin ratio: Return relative to average drawdown	-1.47	-0.77	-0.69

OXLC vs. PASG - Sharpe Ratio Comparison

The current OXLC Sharpe Ratio is -1.23, which is lower than the PASG Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of OXLC and PASG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

OXLC vs. PASG - Drawdown Comparison

The maximum OXLC drawdown since its inception was -74.58%, smaller than the maximum PASG drawdown of -99.43%. Use the drawdown chart below to compare losses from any high point for OXLC and PASG.

Drawdown Indicators

	OXLC	PASG	Difference
Max Drawdown Largest peak-to-trough decline	-74.58%	-99.43%	+24.85%
Max Drawdown (1Y) Largest decline over 1 year	-52.18%	-79.45%	+27.27%
Max Drawdown (3Y) Largest decline over 3 years	-57.17%	-88.21%	+31.04%
Max Drawdown (5Y) Largest decline over 5 years	-57.17%	-98.69%	+41.52%
Max Drawdown (10Y) Largest decline over 10 years	-74.58%	—	—
Current Drawdown Current decline from peak	-48.31%	-99.19%	+50.88%
Average Drawdown Average peak-to-trough decline	-14.02%	-82.82%	+68.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.82%	42.35%	-13.53%

Volatility

OXLC vs. PASG - Volatility Comparison

The current volatility for Oxford Lane Capital Corp. (OXLC) is 5.90%, while Passage Bio, Inc. (PASG) has a volatility of 17.49%. This indicates that OXLC experiences smaller price fluctuations and is considered to be less risky than PASG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	OXLC	PASG	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.90%	17.49%	-11.59%
Volatility (6M) Calculated over the trailing 6-month period	27.68%	100.45%	-72.77%
Volatility (1Y) Calculated over the trailing 1-year period	34.41%	122.61%	-88.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.92%	100.91%	-74.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.48%	99.26%	-56.78%

Dividends

OXLC vs. PASG - Dividend Comparison

OXLC's dividend yield for the trailing twelve months is around 50.72%, while PASG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
OXLC Oxford Lane Capital Corp.	50.72%	35.86%	20.12%	18.83%	17.75%	10.51%	22.46%	19.85%	16.70%	17.91%	22.84%	24.10%
PASG Passage Bio, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both OXLC and PASG in my portfolio?

OXLC and PASG have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, OXLC or PASG?

PASG has higher volatility (17.49%) compared to OXLC (5.90%). In terms of maximum drawdown, OXLC dropped -74.58% vs PASG's -99.43%.

Which has better risk-adjusted returns?

PASG currently has the higher Sharpe Ratio (-0.27 vs -1.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.